Ocean Biomedical, Inc.

Ocean Biomedical, Inc. is a Providence, Rhode Island-based biopharmaceutical company that pursued a business combination with Aesther Healthcare Acquisition Corp (Nasdaq: AEHA), a healthcare-sector blank check company that completed its initial public offering in 2021. As of the 10-Q filed on October 17, 2022, the transaction remained pending regulatory and shareholder approvals; the business combination subsequently closed in early 2023, with Ocean Biomedical continuing as the operating entity. Ocean Biomedical's pipeline spans multiple therapeutic areas including oncology, pulmonary hypertension, and infectious disease. For comprehensive SPAC filing data, deal timelines, and analytics on AEHA and the broader universe of blank check companies, sign up for full access at SpacDesk.